Liposarcoma of oral cavity: Systematic review of cases reported to date and analysis of prognostic factors.
Flávia S C PontesLucas Lacerda de SouzaÉlida N C VulcãoMichelle C de AbreuSarah N MenezesDiogo RezendeHelder Antonio Rebelo PontesPublished in: Head & neck (2020)
The aim of this study was to integrate the available data published on Liposarcomas (LPSs) of the oral cavity into an analysis of its clinical features, treatment modalities, and prognostic factors. An electronic search was undertaken in January 2019. The eligibility criteria included publications that had enough clinical and histological information to confirm the diagnosis. Forty-five publications (104 LPSs) were included. The lesion was more prevalent in males from the fifth to seventh decades of life. Treatment (P = .03) and distant metastasis (P = .0001) were independently associated with survival. A lower possibility of recurrence was statistically associated with age (younger patients) (P = .03), tumor size (smaller than 2.8 cm) (P = .001), and treatment (radical surgery) (P = .04). LPS presents a good survival for patients after 5 years of follow-up (66.4%). Patients who were treated with conservative surgery and presented with distant metastasis showed poor prognosis.
Keyphrases
- prognostic factors
- poor prognosis
- systematic review
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- minimally invasive
- peritoneal dialysis
- lymph node
- long non coding rna
- coronary artery bypass
- randomized controlled trial
- inflammatory response
- free survival
- electronic health record
- big data
- acute coronary syndrome